News

FDA approved use of Lynparza (olaparib tablets) to include treatment of patients with certain types of  Breast Cancer that have become widespread and whose tumors possess inherited…
Read More...

Gobal open-access biologics technology platform company, Wuxi Biologics declares that Dr. Chiang Syin has been appointed by Wuxi Biologics as its Chief Quality Officer accountable for…
Read More...

Boston Scientific Corporation declared optimistic outcomes from the WHISPER randomized controlled Trial.According to the data presented at the 2018 Annual meeting of the North American …
Read More...

Private cancer drug discovery and development company, Sci- Engi-Medco Solutions Inc. (SEMCO) has secured a Small Business Innovation Research Phase 1 contract from the National Cancer…
Read More...

Clinical Biopharmaceutical Company Rgenix declared the Clinical and pre-Clinical results by research collaborators at Rgenix and Rockefeller University disclosing that Liver-X…
Read More...

Shiseido Company asserted that it has obtained Olivo Laboratories. Olivo is mainly a Polaris partners- based startup advancing the dermatological field through proprietary biomaterials…
Read More...

It is noteworthy that Ligand Pharmaceuticals entered into license agreement with Glenmark Pharmaceuticals to use Ligand's OmniAb platform including Omnichicken, Omnirat, OmniMouse and…
Read More...

Sarah Cannon entitled Johanna C. Bendell, MD, to Chief Development Officer. Her responsibilities encompass developing and expanding physician, site and Pharma relationships across the…
Read More...

In a bid to offer qualitative radiation therapy and cancer care services, Alliance healthcare services ventures into a stock purchasing agreement with e+CancerCare in order to function…
Read More...

SkinCure Oncology declared delivery of its  46th image guided superficial radiation therapy system. SkinCure Oncology is into providing a turnkey model for delivery of such systems.…
Read More...

LivaNova PLC commences its enrollement of patients in the Behavior of Valve Leaflets and the Incidence of Reduced Mobility Post-Surgical Aortic Valve Implant Study (“BELIEVE”).  A trial…
Read More...

Boston Scientific Corporation asserted the successful approval of its Spectra Wavewriter Spinal Cord System by U.S FDA to met out paresthesia – based and sub- perception therapy…
Read More...

This is to be brought to notice that WaveForm Technologies has successfully completed its four clinical Trials for its proprietary continuous glucose monitoring system. Patients are…
Read More...

The Medical Ethical Review Committee sought the Xcede Patch clinical trial dossier to initiate first-in-human clinical trial that eyes the treatment of up to 30 patients encountering…
Read More...

Target PharmaSolutions asserts that Novartis has entered into strategic alliance for TARGET-NASH. TARGET-NASH is a longitudinal observational study that assesses adult and pediatric…
Read More...

Adimab partners with Boehringer Ingelheim to discover and optimize antibodies against targets selected by BI who exclusively possesses the right to develop and commercialize therapeutic…
Read More...

It is noteworthy that U.S FDA has accepted an investigational New Drug Application for MORAb-202, an antibody-drug conjugate (ADC), to treat solid tumors that express folate receptor…
Read More...

Aeon global health asserts that Armando Moncada, MD, FCAP appointed as its Chief medical officer of its Anatomy Pathology business line ushering in on board 20 years of expertise and…
Read More...

Syndax Pharmaceuticals that is developing entinostat and SNDX-6352 in multiple cancer indications declared collaboration with a member of Roche Group, Genentech to evaluate  the…
Read More...

Kalorama states that IVD industry has embarked on  an approach to advance IVD innovations in Sepsis. Sepsis is characterized by tedious detection in its early stages as  fever,…
Read More...